THE IMPACT OF HIV VIRAL LOAD ON THE SURVIVAL OF PATIENTS WITH HIV INFECTION DURING А 5-YEAR FOLLOW-UP
DOI:
https://doi.org/10.11603/1681-2786.2018.2.9363Keywords:
HIV, HAART, CD4 T-lymphocytes, viral load.Abstract
Purpose: based on a 5-year follow-up of a cohort of HIV-infected patients who were assigned highly active antiretroviral therapy, to assess the impact of viral load of HIV and CD4 RNA on the beginning of highly active antiretroviral therapy on mortality.
Materials and Methods. The analysis of patients was carried out taking into account clinical and laboratory parameters. Mathematical and statistical methods were used: descriptive statistics of quantitative data in groups; correlation analysis (correlation coefficient – rs).
Results. All patients received highly active antiretroviral therapy (HAART) for at least 5 years. Immunophenotyping of peripheral blood showed the following results: median (IU, 25–75 percentile) CD4 + level was 186 (90–262) copies / ml, viral load-75.358 (19.091–326.273) RNA HIV copies/ml. Over five years of follow-up, 63 patients died. If we take into account the annual mortality, a large percentage of HIV patients died in the first 12 months of treatment and amounted to 58.73%. Over the next two years, 11.11 % and 14.28 % died annually, respectively. In the fourth year after the start of highly active antiretroviral therapy, 11.11 % of patients died. For the 5th year of the HAART died 4.76 % of patients.
Сonclusions. In HIV-infected patients, who were assigned HAART to, there is a certain relationship between the number of t-lymphocytes-helpers and viral load (rs=-0.821; p=0.000) during the 5-year follow-up. The highest accumulated risk of death – 0.1, was found in groups of patients with a greater degree of immunosuppression.
References
Nakaz MOZ Ukrainy № 551 vіd 12.07.2010 r. “Pro zatverdzhennia klіnіchnoho protokolu antiretrovіrusnoi terapіi VІL-іnfektsіi u doroslykh ta pіdlіtkіv” [Order of the Ministry of Health of Ukraine dated July No 551 of 12.07.2010. “About the solidification of the clinical protocol of antiretroviral therapy VIL-infectious diseases in the elderly and adolescents”]. [in Ukrainian].
Pokrovskaya A.V.(2010). Faktory, vliyayushchie na techenie VICH–infektsii [Factors influencing the course of HIV infection]. Epidemiologiya i infektsionnye bolezni – Epidemiology and Infectious Diseases, 3, 60-63 [in Russian].
Azar, M. M., Springer, S. A., Meyer, J. P., & Altice F. L. (2010). A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol. Depend., 112 (3), 178-193.
Atkinson, M. J. & Petrozzino J. J. (2009). An evidence-based review of treatment-related determinants of patients’ nonadherence to HIV medications. II AIDS Patient Care STDS, 23 (11), 903-914.
Boulware, D. R., Meya, D. В. & Bergemann, T. L. (2010). Clinical features and serum biomarkers in HIV immune reconstitution inflammatory synd bryptococcal meningitis: a prospective cohort study. PLoS Med. 7, (12), 380-384.
Ammassari, A., Trotta, M. P., Murri, R. & et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J. Acquir. Immune. Defic. Syndr., 31 (3), 123-127.
Trinchieri G. (2007). Interleukin-10 production by effector T cells: Thl cells show self- control. J. Exp. Med. 204 (2), 239-243.
Wojcicki J. M. (2005). Socioeconomic status as a risk factor for HIV infection in women in East, Central and Southern Africa: a systematic review. J. Biosoc. Sci. 37 (1), 1-36.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).